Unique ID issued by UMIN | UMIN000035228 |
---|---|
Receipt number | R000040131 |
Scientific Title | Restoration of bone defects at craniotomy using bone graft substitutes made of hydroxyapatite and collagen composite. |
Date of disclosure of the study information | 2019/01/01 |
Last modified on | 2020/12/13 09:30:08 |
Restoration of bone defects at craniotomy using bone graft substitutes made of hydroxyapatite and collagen composite.
Restoration of bone defects at craniotomy using bone graft substitutes made of hydroxyapatite and collagen composite.
Restoration of bone defects at craniotomy using bone graft substitutes made of hydroxyapatite and collagen composite.
Restoration of bone defects at craniotomy using bone graft substitutes made of hydroxyapatite and collagen composite.
Japan |
Bone defect caused by craniotomy
Neurosurgery |
Others
NO
Bone defect occurring during craniotomy is osteolytic occurs over time, a problem in aesthetic surface and intensity surface. The aim is to clarify the hypothesis that using bone graft substitutes made of hydroxyapatite and collagen composite for the bone defect part, it is replaced with new bone and the strength and aesthetic aspects are improved.
Safety,Efficacy
Treatment success rate of artificial bone and autogenous bone dust replacement part
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Medicine |
At the time of surgery, artificial bone is placed 1-6cc.
At the time of surgery, bone dust occurred at craniotomy is placed.
20 | years-old | <= |
90 | years-old | >= |
Male and Female
1)Bilateral frontal craniotomy or fronto temporal craniotomy is scheduled.
2)There is no history of surgery such as craniotomy in the scheduled opening range.
3)The age at agreement is 20 years old or over and 90 years old or younger.
4)Consent in writing from the person is obtained for the study participants.
1) It is known that it is allergic to allergy patients who need treatment, or other porcine collagen-containing preparations.
2) There is a history of inflammation in the skull.
3) received immunosuppressive therapy Within three months ago.
4) pregnant, lactating, or it might be pregnant.
5) undergoing dialysis.
6) has a active and/or progressive malignant tumor.
7) Diabetes mellitus with poor control.
8) has a calcium metabolic diseases requiring treatment.
9) has a bone targeted hormone metabolism abnormalities requiring treatment.
10) has an immune deficiency disease.
31
1st name | Tsutomu |
Middle name | |
Last name | Yoshikane |
Shimane University Faculty of Medicine
Neurosurgery
6938501
89-1, Enya-cho, Izumo-shi, Shimane, Japan
0853-20-2245
ytsutomu@med.shimane-u.ac.jp
1st name | Tsutomu |
Middle name | |
Last name | Yoshikane |
Shimane University Faculty of Medicine
Neurosurgery
6938501
89-1, Enya-cho, Izumo-shi, Shimane, Japan
0853-20-2245
ytsutomu@med.shimane-u.ac.jp
Shimane University Faculty of Medicine Department of Neurosurgery
Shimane University
Other
Medical Ethics Committee Secretariat of Shimane University Faculty of Medicine
89-1, Enya-cho, Izumo-shi, Shimane, Japan
0853202515
kenkyu@med.shimane-u.ac.jp
NO
2019 | Year | 01 | Month | 01 | Day |
Unpublished
Preinitiation
2018 | Year | 11 | Month | 29 | Day |
2019 | Year | 01 | Month | 01 | Day |
2023 | Year | 06 | Month | 30 | Day |
2018 | Year | 12 | Month | 12 | Day |
2020 | Year | 12 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040131
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |